Intellia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.About NTLA
Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases.
CEOJohn M. Leonard
CEOJohn M. Leonard
Employees526
Employees526
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2014
Founded2014
Employees526
Employees526
NTLA Key Statistics
Market cap2.72B
Market cap2.72B
Price-Earnings ratio-5.08
Price-Earnings ratio-5.08
Dividend yield—
Dividend yield—
Average volume1.18M
Average volume1.18M
High today$28.23
High today$28.23
Low today$26.61
Low today$26.61
Open price$26.98
Open price$26.98
Volume1.04M
Volume1.04M
52 Week high$47.48
52 Week high$47.48
52 Week low$22.67
52 Week low$22.67
NTLA News
Benzinga 9h
Smart Money Is Betting Big In NTLA Options - Intellia Therapeutics - BenzingaLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Intellia Therapeutics NTLA, and it's something market players shouldn't i...
TipRanks 7d
Intellia Ends Gene Editing Deal with Regeneron Pharmaceuticals - TipRanks.com - TipRanksIntellia Therapeutics (NTLA) has shared an update. Intellia Therapeutics has decided to withdraw from its 2020 collaboration with Regeneron Pharmaceuticals on...
Analyst ratings
79%
of 28 ratingsBuy
78.6%
Hold
21.4%
Sell
0%